ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,738.17
-0.13%
Dow Jones
42,313.00
0.33%
US Dollar vs MXN
19.7087
0.44%
Brent Oil
72.01
1.49%
Bitcoin
65,821.38
0.98%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. LENSAR Inc (LNSR)

  7. LENSAR Inc (LNSR) Noticias

LNSR

LENSAR (LNSR)

LENSAR Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LNSR
FechaHoraFuenteTítuloSímboloCompañía
06/09/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNSRLENSAR Inc
04/09/202415:01Business WireLENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LNSRLENSAR Inc
04/09/202407:00Business WireLENSAR to Participate in Two Upcoming Investor ConferencesNASDAQ:LNSRLENSAR Inc
08/08/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNSRLENSAR Inc
08/08/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNSRLENSAR Inc
08/08/202406:00Business WireLENSAR Reports Second Quarter 2024 Results and Provides Business UpdateNASDAQ:LNSRLENSAR Inc
07/08/202406:00Business WireLENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European UnionNASDAQ:LNSRLENSAR Inc
01/08/202406:00Business WireLENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:LNSRLENSAR Inc
23/05/202407:00Business WireLENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceNASDAQ:LNSRLENSAR Inc
09/05/202406:00Business WireLENSAR Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:LNSRLENSAR Inc
02/05/202407:00Business WireLENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:LNSRLENSAR Inc
05/03/202415:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LNSRLENSAR Inc
04/03/202415:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LNSRLENSAR Inc
04/03/202406:00Business WireLENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:LNSRLENSAR Inc
26/02/202407:00Business WireLENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024NASDAQ:LNSRLENSAR Inc
11/12/202315:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LNSRLENSAR Inc
09/11/202306:00Business WireLENSAR Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:LNSRLENSAR Inc
02/11/202307:03Business WireLENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023NASDAQ:LNSRLENSAR Inc
11/08/202305:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LNSRLENSAR Inc
10/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LNSRLENSAR Inc
09/08/202306:00Business WireLENSAR Reports Second Quarter 2023 Results and Provides Business UpdateNASDAQ:LNSRLENSAR Inc
04/08/202315:04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LNSRLENSAR Inc
24/07/202306:00Business WireLENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology GroupsNASDAQ:LNSRLENSAR Inc
26/06/202315:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LNSRLENSAR Inc
20/06/202315:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LNSRLENSAR Inc
20/06/202310:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LNSRLENSAR Inc
08/06/202306:13Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LNSRLENSAR Inc
06/06/202316:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LNSRLENSAR Inc
06/06/202316:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LNSRLENSAR Inc
26/05/202305:00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:LNSRLENSAR Inc
 Showing the most relevant articles for your search:NASDAQ:LNSR

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NYSE
MCD
McDonalds
NYSE
NKE
Nike
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
NYSE
JPM
JP Morgan Chase
SPI
SP500
S&P 500
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados